3D Printed Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Technology (Inkjet Printing, Fused Deposition Modeling, Stereolithography, ZipDose Technology, Others), By Application (Orthopedic, Neurology, Dental, Others), By End User (Hospitals & Clincs, Academic & Research Institutions, Others), By Region

December 2022 | 119 pages | ID: 33BF635A9B2AEN
TechSci Research

Abstracts

The global 3d printed drugs market is anticipated to witness an impressive growth during the forecast period. This can be ascribed to increasing awareness amongst people and patients regarding the benefits associated with the usage of 3D printed drugs. Besides increasing number of patients suffering from dysphagia is expected to support the market growth in the coming years. Dysphagia is characterized by difficulty in swallowing. In this disease, it takes more time and effort to move food or liquid from mouth to stomach. 3D printed drugs are drugs created by 3D printing technology that are used to treat patients suffering from dysphagia. 3D printed drugs have a porous structure that can rapidly disintegrate in the mouth. Besides, increasing investments by government organizations for inventing new drugs related to different diseases couples with growing awareness regarding usage of 3D printed drugs among people and healthcare providers will further boost the market growth in the forecast period. Furthermore, growing popularity of personalized medicine is further expected to create lucrative opportunities for the market growth.

Increasing Prevalence of Chronic Diseases

The growing prevalence of chronic diseases such as diabetes, cancer, cardiovascular diseases, renal problems, among others across the globe is expected to create lucrative opportunities for the growth of global 3D printed drugs market. According to global cancer observatory, around 19,292,789 new cancer cases were reported worldwide in 2020, with breast cancer, lung cancer, colorectum cancer, prostate cancer and stomach cancer being the most prevalent types. This in turn is expected to increase the demand for 3D printed drugs for the treatment of different types of cancers. Additionally, growing geriatric population across the globe which is susceptible to various diseases requires medications that are not only effective but also affordable, thereby fuelling the growth of global 3D printed drugs market.

Benefits Associated With 3D Printed Drugs

There are numerous benefits associated with the use of 3D Printed Drugs such as using this technique medicines can be produced in small batches with carefully tailored shapes, dosages, and sizes, among others. In addition, the use of 3D printing technology can significantly reduce manufacturing costs. This in turn is expected to increase investments in this space, thereby supporting the market growth during the forecast period. However, increased awareness of the benefits of these medications, such as their immediate solubility, faster manufacturing time, reduced waste, and easy on-demand manufacturing is likely to create multiple prospects for market growth.

Market Segmentation

The Global 3D Printed Drugs market can be segmented by technology, by application, by end user, and by region. Based on technology, the market can be categorized into inkjet printing, fused deposition modeling, stereolithography, zipdose technology, and others. Based on application, the market can be fragmented into orthopedic, neurology, dental, and others. Based on end user, the market can be grouped into hospitals & clincs, academic & research institutions, and others. Regionally, North America dominated the market among Europe, Asia Pacific, Middle East & Africa, and South America. Among the different countries, United States dominated the Global 3D Printed Drugs Market on account of growing adoption, use and availability of personalized medicines in the United States. The number of personalized medicines available in the United States in 2020 were around 286.

Market Players

Aprecia Pharmaceuticals, LLC., FabRx Ltd., Merck & Co. Inc., Triastek, Inc., GlaxoSmithKline plc., Formac Pharmaceuticals N.V., AstraZeneca plc, Extend Biosciences, Inc., Affinity Therapeutics, LLC, Osmotica Pharmaceuticals Corporation are some of the leading players operating in the Global 3D Printed Drugs Market.

Report Scope:

In this report, Global 3D Printed Drugs Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• 3D Printed Drugs Market, By Technology:
• Inkjet Printing
• Fused Deposition Modeling
• Stereolithography
• Zip Dose Technology
• Others
• 3D Printed Drugs Market, By Application:
• Orthopedic
• Neurology
• Dental
• Others
• 3D Printed Drugs Market, By End User:
• Hospital & Clinics
• Academic & Research Institutions
• Others
• 3D Printed Drugs Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• France
• Germany
• United Kingdom
• Italy
• Spain
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Turkey
• Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global 3D Printed Drugs Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. IMPACT OF COVID-19 ON GLOBAL 3D PRINTED DRUGS MARKET

5. VOICE OF CUSTOMER

6. GLOBAL 3D PRINTED DRUGS MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Technology (Inkjet Printing, Fused Deposition Modeling, Stereolithography, ZipDose Technology, Others)
  6.2.2. By Application (Orthopedic, Neurology, Dental, Others)
  6.2.3. By End User (Hospitals & Clincs, Academic & Research Institutions, Others)
  6.2.4. By Company (2021)
  6.2.5. By Region
6.3. Market Map

7. NORTH AMERICA 3D PRINTED DRUGS MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Technology
  7.2.2. By Application
  7.2.3. By End User
  7.2.4. By Country
7.3. North America: Country Analysis
  7.3.1. United States 3D Printed Drugs Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Technology
      7.3.1.2.2. By Application
      7.3.1.2.3. By End User
  7.3.2. Canada 3D Printed Drugs Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Technology
      7.3.2.2.2. By Application
      7.3.2.2.3. By End User
  7.3.3. Mexico 3D Printed Drugs Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Technology
      7.3.3.2.2. By Application
      7.3.3.2.3. By End User

8. EUROPE 3D PRINTED DRUGS MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Technology
  8.2.2. By Application
  8.2.3. By End User
  8.2.4. By Country
8.3. Europe: Country Analysis
  8.3.1. France 3D Printed Drugs Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Technology
      8.3.1.2.2. By Application
      8.3.1.2.3. By End User
  8.3.2. Germany 3D Printed Drugs Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Technology
      8.3.2.2.2. By Application
      8.3.2.2.3. By End User
  8.3.3. United Kingdom 3D Printed Drugs Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Technology
      8.3.3.2.2. By Application
      8.3.3.2.3. By End User
  8.3.4. Italy 3D Printed Drugs Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Technology
      8.3.4.2.2. By Application
      8.3.4.2.3. By End User
  8.3.5. Spain 3D Printed Drugs Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Technology
      8.3.5.2.2. By Application
      8.3.5.2.3. By End User

9. ASIA-PACIFIC 3D PRINTED DRUGS MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Technology
  9.2.2. By Application
  9.2.3. By End User
  9.2.4. By Country
9.3. Asia-Pacific: Country Analysis
  9.3.1. China 3D Printed Drugs Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Technology
      9.3.1.2.2. By Application
      9.3.1.2.3. By End User
  9.3.2. India 3D Printed Drugs Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Technology
      9.3.2.2.2. By Application
      9.3.2.2.3. By End User
  9.3.3. Japan 3D Printed Drugs Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Technology
      9.3.3.2.2. By Application
      9.3.3.2.3. By End User
  9.3.4. South Korea 3D Printed Drugs Market Outlook
    9.3.4.1. Market Size & Forecast
      9.3.4.1.1. By Value
    9.3.4.2. Market Share & Forecast
      9.3.4.2.1. By Technology
      9.3.4.2.2. By Application
      9.3.4.2.3. By End User
  9.3.5. Australia 3D Printed Drugs Market Outlook
    9.3.5.1. Market Size & Forecast
      9.3.5.1.1. By Value
    9.3.5.2. Market Share & Forecast
      9.3.5.2.1. By Technology
      9.3.5.2.2. By Application
      9.3.5.2.3. By End User

10. SOUTH AMERICA 3D PRINTED DRUGS MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Technology
  10.2.2. By Application
  10.2.3. By End User
  10.2.4. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil 3D Printed Drugs Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Technology
      10.3.1.2.2. By Application
      10.3.1.2.3. By End User
  10.3.2. Argentina 3D Printed Drugs Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Technology
      10.3.2.2.2. By Application
      10.3.2.2.3. By End User
  10.3.3. Colombia 3D Printed Drugs Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Technology
      10.3.3.2.2. By Application
      10.3.3.2.3. By End User

11. MIDDLE EAST AND AFRICA 3D PRINTED DRUGS MARKET OUTLOOK

11.1. Market Size & Forecast
  11.1.1. By Value
11.2. Market Share & Forecast
  11.2.1. By Technology
  11.2.2. By Application
  11.2.3. By End User
  11.2.4. By Country
11.3. MEA: Country Analysis
  11.3.1. South Africa 3D Printed Drugs Market Outlook
    11.3.1.1. Market Size & Forecast
      11.3.1.1.1. By Value
    11.3.1.2. Market Share & Forecast
      11.3.1.2.1. By Technology
      11.3.1.2.2. By Application
      11.3.1.2.3. By End User
  11.3.2. Saudi Arabia 3D Printed Drugs Market Outlook
    11.3.2.1. Market Size & Forecast
      11.3.2.1.1. By Value
    11.3.2.2. Market Share & Forecast
      11.3.2.2.1. By Technology
      11.3.2.2.2. By Application
      11.3.2.2.3. By End User
  11.3.3. UAE 3D Printed Drugs Market Outlook
    11.3.3.1. Market Size & Forecast
      11.3.3.1.1. By Value
    11.3.3.2. Market Share & Forecast
      11.3.3.2.1. By Technology
      11.3.3.2.2. By Application
      11.3.3.2.3. By End User
  11.3.4. Turkey 3D Printed Drugs Market Outlook
    11.3.4.1. Market Size & Forecast
      11.3.4.1.1. By Value
    11.3.4.2. Market Share & Forecast
      11.3.4.2.1. By Technology
      11.3.4.2.2. By Application
      11.3.4.2.3. By End User
  11.3.5. Egypt 3D Printed Drugs Market Outlook
    11.3.5.1. Market Size & Forecast
      11.3.5.1.1. By Value
    11.3.5.2. Market Share & Forecast
      11.3.5.2.1. By Technology
      11.3.5.2.2. By Application
      11.3.5.2.3. By End User

12. MARKET DYNAMICS

12.1. Drivers
12.2. Challenges

13. MARKET TRENDS & DEVELOPMENTS

14. COMPETITIVE LANDSCAPE

14.1. Aprecia Pharmaceuticals, LLC.
14.2. FabRx Ltd.
14.3. Merck & Co. Inc.
14.4. Triastek, Inc.
14.5. GlaxoSmithKline plc.
14.6. Formac Pharmaceuticals N.V.
14.7. AstraZeneca plc
14.8. Extend Biosciences, Inc.
14.9. Affinity Therapeutics, LLC
14.10. Osmotica Pharmaceuticals Corporation

15. STRATEGIC RECOMMENDATIONS